If you currently inject on Mondays and want to switch to Fridays, your next interval would be 11 days instead of 7
No recovery time for a routine vitamin or hydration drip
The first discovery of a molecular mechanism that contributes to the subcellular targeting of GABAergic synapses
Biochemical analyses were performed on maternal serum, fetal brains, and adult prefrontal cortex, measuring IL-6 and IL-17a (ELISA), parvalbumin-positive interneurons (immunofluorescence), and GABA/glutamate levels (HPLC)

enthusiasm dramatically outpaces science FDA Category 2 classifications for peptides like Semax reflect absence of FDA-standard evidence, not documented harmsRussian clinical experience suggests reasonable safety, but long-term effects by Western standards remain uncharacterized Established interventionsexercise, Mediterranean diet, sleep optimization, cardiovascular risk management, cognitive engagementhave far more consistent evidence than any peptide for dementia risk reduction For Research Prioritization Compounds meriting continued investigation: GLP-1 Agonists: Prevention trials in preclinical/presymptomatic populations, testing compounds with better brain penetration (dulaglutide, lixisenatide) SS-31/Elamipretide: Cognitive outcomes in mitochondrial disease populations, potential expansion to brain aging indications P21: Phase I human trials to establish safety, pharmacokinetics, and proof-of-mechanism for CNTF-pathway neurogenesis Klotho: Watch for Phase 1 results from Jocasta Neuroscience (expected 2027-2028)
